Advanced search
Publication Cover
International Journal of Neuroscience Latest Articles
Submit an article Journal homepage
41
Views
0
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE

A hospital-based retrospective study: early recognition of neuronal surface antibodies by clinical manifestations and CSF inflammation indicators in patients with unexplained epilepsy

Siqi Dinga Yiwu Central Hospital affiliated to Wenzhou Medical University, Yiwu City, Zhejiang Province, People’s Republic of ChinaView further author information
,
JingPing Wangb First Affiliated Hospital of Wenzhou Medical University, Wenzhou City, Zhejiang Province, People’s Republic of ChinaView further author information
,
Fangfang Yangb First Affiliated Hospital of Wenzhou Medical University, Wenzhou City, Zhejiang Province, People’s Republic of ChinaView further author information
,
Zhongming Caib First Affiliated Hospital of Wenzhou Medical University, Wenzhou City, Zhejiang Province, People’s Republic of ChinaView further author information
&
Yucang Heb First Affiliated Hospital of Wenzhou Medical University, Wenzhou City, Zhejiang Province, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Received 28 Jul 2023, Accepted 05 Sep 2023, Published online: 12 Sep 2023

References

  • Dubey D, Alqallaf A, Hays R, et al. Neurological autoantibody prevalence in epilepsy of unknown etiology. JAMA Neurol. 2017;74(4):397–402. doi:10.1001/jamaneurol.2016.5429.
  • Dalmau J, Graus F. Antibody-mediated encephalitis. N Engl J Med. 2018;378(9):840–851. doi:10.1056/NEJMra1708712.
  • Gaspard N, Foreman BP, Alvarez V, et al. New-onset refractory status epilepticus: etiology, clinical features, and outcome. Neurology. 2015;85(18):1604–1613. doi:10.1212/WNL.0000000000001940.
  • Brenner T, Sills GJ, Hart Y, et al. Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia. 2013;54(6):1028–1035. doi:10.1111/epi.12127.
  • Baumgartner T, Pitsch J, Olaciregui-Dague K, et al. Seizure underreporting in LGI1 and CASPR2 antibody encephalitis. Epilepsia. 2022;63(9):e100–e105. doi:10.1111/epi.17338.
  • Behnaz A, Masoud E, Mohammadreza N, et al.. Neuronal autoantibodies in focal epilepsy with or without mesial temporal sclerosis. Iran J Neurol. 2019;18:13–18.
  • Gozubatik-Celik G, Ozkara C, Ulusoy C, et al. Anti-Neuronal autoantibodies in both drug responsive and resistant focal seizures with unknown cause. Epilepsy Res. 2017;135:131–136. doi:10.1016/j.eplepsyres.2017.06.008.
  • Gu Y, Zhong M, He L, et al. Epidemiology of antibody-positive autoimmune encephalitis in southwest China: a multicenter study. Front Immunol. 2019;10:2611. doi:10.3389/fimmu.2019.02611.
  • Baysal-Kirac L, Tuzun E, Altindag E, et al. Are there any specific EEG findings in autoimmune epilepsies? Clin EEG Neurosci. 2016;47(3):224–234. doi:10.1177/1550059415595907.
  • Dubey D, Singh J, Britton JW, et al. Predictive models in the diagnosis and treatment of autoimmune epilepsy. Epilepsia. 2017;58(7):1181–1189. doi:10.1111/epi.13797.
  • Steriade C, Gillinder L, Rickett K, et al. Discerning the role of autoimmunity and autoantibodies in epilepsy. JAMA Neurol. 2021;78(11):1383–1390. doi:10.1001/jamaneurol.2021.3113.
  • Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol. 2011;69(5):892–900. doi:10.1002/ana.22307.
  • Höftberger R, van Sonderen A, Leypoldt F, et al. Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients. Neurology. 2015;84(24):2403–2412. doi:10.1212/WNL.0000000000001682.
  • Höftberger R, Titulaer MJ, Sabater L, et al. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology. 2013;81(17):1500–1506. doi:10.1212/WNL.0b013e3182a9585f.
  • Petit-Pedrol M, Armangue T, Peng X, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol. 2014;13(3):276–286. doi:10.1016/S1474-4422(13)70299-0.
  • Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391–404. doi:10.1016/S1474-4422(15)00401-9.
  • Xu LIU, Bo Y, Rui W, et al. Seizure outcomes in patients with anti-NMDAR encephalitis: a follow-up study. Epilepsia. 2017;58:2104–2111.
  • Rada A, Birnbacher R, Gobbi C, et al. Seizures associated with antibodies against cell surface antigens are acute symptomatic and not indicative of epilepsy: insights from long-term data. J Neurol. 2021;268(3):1059–1069. doi:10.1007/s00415-020-10250-6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.